[Microbiota and inflammatory bowel disease: an update.]

Area of Science:

• Microbiology
• Immunology
• Gastroenterology

Background:

• The gut microbiota is integral to host health, influencing nutrition, metabolism, immunity, and disease.
• Alterations in gut microbiota composition and function are implicated in inflammatory bowel disease (IBD).

Purpose of the Study:

• To analyze the functions and interactions of the gut microbiota in host health and disease.
• To investigate the role of microbial dysbiosis in IBD pathogenesis.
• To explore therapeutic strategies for modulating the gut microbiota in IBD.

Main Methods:

• Studies on mouse models and human populations to analyze gut microbiota.
• Characterization of microbial signatures associated with IBD.
• Evaluation of indirect (antibiotics, probiotics) and direct (fecal microbiota transplantation) modulation techniques.

Main Results:

• IBD is associated with impaired gut microbiota composition, biodiversity, stability, and function.
• Specific microbial shifts in IBD include decreased F. prausnitzii, increased Proteobacteria, and altered fungal and viral ratios.
• Gut microbiota modulation strategies have clinical implications for IBD management.

Conclusions:

• Gut microbiota alterations are a hallmark of IBD.
• Targeting the gut microbiota offers potential therapeutic avenues for IBD.
• Personalized approaches based on gut microbiota characterization will likely advance IBD treatment.